Latest CardioSignal News & Updates

See the latest news and media coverage for CardioSignal. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
CardioSignal

Smartphone-based atrial fibrillation detection device

cardiosignal.com
Headquarters
Turku, Finland
Founded year
2016
Company type
Private company
Number of employees
30–50

Last updated

Latest news about CardioSignal

In short: CardioSignal raised $10 million in Series A funding and achieved EU MDR Class IIb certification for its smartphone-based heart monitoring technology.

Company announcements

CardioSignal

CardioSignal announces MDR Class IIb certification and new SDK model

CardioSignal achieved EU MDR Class IIb certification and will offer a new SDK partnership model for integrating atrial fibrillation detection into partner apps.

Unlock all announcements with a

Media coverage

Medscape

FDA Approves Multimodal CardioTag Monitor

The new wearable technology can assess multiple cardiovascular metrics, including electrical impulses and blood flow, to alert patients and clinicians to worsening heart failure and...

Tekniikka&Talous

5000 over 50-year-olds are offered a free app for trial that identifies a common heart rhythm disorder. Heart problems. In the illustration image, Meilahti's joint emergency services. IMAGE: Henri Kärkkäinen 8.6.202518:02 Rony Hopeakangas 5000 for 50-75-year-olds are offered..

5000 over 50-year-olds are offered a free app for trial that identifies a common heart rhythm disorder. Heart problems. In the illustration image, Meilahti's joint emergency services. IMAGE: Henri Kärkkäinen 8.6.202518:02 Rony Hopeakangas 5000 for 50-75-year-olds are offered...

AHA Journals

Abstract 12517: CardioSignal Smartphone Application Detects Atrial Fibrillation in Heart Failure Population

Unlock all articles with a

Never miss news about CardioSignal

Track CardioSignal and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.